tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Jonathan Chang, 110 are a BUY (67.9%), 52 are a HOLD (32.1%).
Analyst Jonathan Chang, carries an average stock price target met ratio of 51.28% that have a potential upside of 31.15% achieved within 215 days.
Jonathan Chang’s has documented 302 price targets and ratings displayed on 24 stocks. The coverage was on Healthcare, Consumer Cyclical, Communication Services sectors.
Most recent stock forecast was given on REPL, Replimune Group at 04-Aug-2026.
Analyst best performing recommendations are on IMGN (IMMUNOGEN).
The best stock recommendation documented was for RVMD (REVOLUTION MEDICINES) at 4/13/2026. The price target of $147 was fulfilled within 1 day with a profit of $10.7 (7.85%) receiving and performance score of 78.5.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Sell
$1
$-0.01 (-0.99%)
$4
3 years 2 months 18 days ago
(10-Aug-2023)
3/4 (75%)
$0.18 (21.95%)
245
Buy
$5
$3.99 (395.05%)
3 years 9 months 25 days ago
(03-Jan-2023)
0/2 (0%)
$3.33 (199.40%)
Buy
$9
$8.22 (1053.85%)
$9
3 years 11 months 19 days ago
(09-Nov-2022)
2/3 (66.67%)
$1.29 (98.13%)
340
Hold
$3
$1.99 (197.03%)
4 years 5 months 19 days ago
(09-May-2022)
1/5 (20%)
$1.46 (94.81%)
377
Buy
$6
$5.22 (669.23%)
$16
7 years 5 months 21 days ago
(07-May-2019)
1/3 (33.33%)
$6.36 (92.59%)
388
Which stock is Jonathan Chang most bullish on?
Which stock is Jonathan Chang most reserved on?
